scispace - formally typeset
H

Hodjattallah Rabbani

Researcher at Avicenna Research Institute

Publications -  89
Citations -  2821

Hodjattallah Rabbani is an academic researcher from Avicenna Research Institute. The author has contributed to research in topics: Antibody & Chronic lymphocytic leukemia. The author has an hindex of 26, co-authored 78 publications receiving 2588 citations. Previous affiliations of Hodjattallah Rabbani include Gifu University & Karolinska University Hospital.

Papers
More filters
Journal ArticleDOI

Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer

TL;DR: HPV‐16 is mainly episomal in tonsillar cancer, the viral load showed a wide distribution and the clinical outcome in this study was better when the HPV load was higher.
Journal ArticleDOI

Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.

TL;DR: Gene expression analysis reverse transcription‐polymerase chain reaction of ROR1 revealed that all patients with CLL spontaneously expressed Ror1 mRNA whereas enriched blood B and T cells as well as granulocytes from healthy donors were negative, while normal blood leukocytes were negative.
Journal ArticleDOI

IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

TL;DR: Evidence is provided that CD94/NKG2A receptors play an important role in regulating T cell activity against tumors and shows that IFN-gamma modulation of target cells may shift the balance of triggering and inhibitory signals to T cells, turning off their cytolytic activity.
Journal ArticleDOI

X‐Linked Agammaglobulinemia and Other Immunoglobulin Deficiencies

TL;DR: The first stages of B-cell progenitors have, as yet, not been identified, and the earliest lymphoid cells committed to becoming B cells are normally referred to as pro-B cells.